cGxP.wire https://validator.w3.org/feed/docs/rss2.html Waters Wins FDA Clearance for At-Home HPV Cancer Test Biocon Launches Denosumab Biosimilars in U.S. Vanda Initiates Thetis Trial for GLP-1 Vomiting Prevention Dyno AI Capsid Licensed by Astellas for Gene Therapy Garda to Acquire Assertio in $125M Pharma Deal Fortrea Launches AI-Powered FIT Platform to Transform Clinical Trials Merit Medical Acquires View Point to Expand Oncology Devices Immutrin Raises $87M to Advance Amyloidosis Antibody Therapy ArkBio Advances AK0406 Phase I Trial for Influenza BioOra and Octane Expand CAR-T Manufacturing Globally GSK Secures China Approval for Exdensur in Nasal Polyps Treatment MemorialCare Joins FASTEST Trial for Stroke Therapy Avista Healthcare Partners Acquires Bentec to Expand MedTech Manufacturing Phanes Advances Spevatamig to Expansion in BTC Trial Anumana Gains FDA Clearance for ECG-AI Amyloidosis Tool Saladax Expands Global Access to Drug Monitoring Tests Insmed CEDAR Study Misses Endpoints in HS Trial Nuvalent Submits NDA for Neladalkib in ALK Lung Cancer Lupin Gains US FDA Nod for Dapagliflozin Tablets Supira Medical Gains FDA Nod for SUPPORT II Trial Alloy and Biogen Partner on Antisense Drug Platform Lumonus and MSK Advance AI Radiation Planning Resolve and Pasteur Advance cfRNA Autoimmune Research bioAffinity Showcases CyPath Lung at Cleveland Clinic Johnson & Johnson Launches VARIPULSE Pro in Europe Apotex Wins Approval for DENOZA Biosimilar in Canada Singlomics Doses First Patient in DXP-106 Trial NanoViricides Files Measles Drug for Rare Disease Status Fortitude Advances T-Cell Therapy for Axial Disease Gilead Acquires Tubulis to Boost Oncology Pipeline ALS Research at Risk from Proposed FY27 Budget Cuts Artivion Secures FDA Approval for NEXUS Aortic System Kiora Raises $24M to Advance Retinal Therapies Shionogi Shows Strong Fetroja Real-World Effectiveness Alzamend Reports Phase II AL001 Brain Data Gains NurExone Strengthens GMP Exosome Supply via BioXtek Savara MOLBREEVI MAA Accepted by UK MHRA for PAP Acadia Expands DAYBUE STIX Access for Rett Syndrome CGBIO Secures $38M Deals at IMCAS 2025 Expansion Boost CuraTeQ Reports Positive Phase 3 Results for BP11 Biosimilar Sanofi Lunsekimig Shows Strong Phase 2 Results in Asthma Renovare Therapeutics Launches with $33.5M ARPA-H Support Praxis Precision Medicines Reports Strong Elsunersen Trial Oncolytics Advances Pelareorep Toward Anal Cancer Approval Lilly Launches Foundayo Oral GLP-1 Weight Loss Drug Medicus Pharma Advances Teverelix Phase 2 FDA Strategy Egg Medical Launches EggNest Flex Apron-Free Protection Bora Biologics Achieves 2,000L Scale-Up Milestone in US Amgen TEPEZZA Subcutaneous Trial Shows Strong Phase 3 Results Decoy Therapeutics Advances AI Antiviral Pipeline Fast